Enterprise Bank & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329K | Sell |
2,618
-45
| -2% | -$5.65K | 0.12% | 98 |
|
2025
Q1 | $364K | Sell |
2,663
-201
| -7% | -$27.5K | 0.14% | 97 |
|
2024
Q4 | $438K | Sell |
2,864
-1,138
| -28% | -$174K | 0.14% | 85 |
|
2024
Q3 | $776K | Sell |
4,002
-569
| -12% | -$110K | 0.25% | 64 |
|
2024
Q2 | $1.06M | Sell |
4,571
-49
| -1% | -$11.4K | 0.36% | 55 |
|
2024
Q1 | $996K | Buy |
4,620
+4
| +0.1% | +$863 | 0.34% | 58 |
|
2023
Q4 | $1.19M | Sell |
4,616
-39
| -0.8% | -$10.1K | 0.43% | 51 |
|
2023
Q3 | $1.2M | Buy |
4,655
+55
| +1% | +$14.1K | 0.49% | 46 |
|
2023
Q2 | $1.31M | Buy |
4,600
+203
| +5% | +$57.8K | 0.5% | 48 |
|
2023
Q1 | $1.22M | Buy |
4,397
+7
| +0.2% | +$1.95K | 0.53% | 48 |
|
2022
Q4 | $1.22M | Sell |
4,390
-10
| -0.2% | -$2.77K | 0.58% | 48 |
|
2022
Q3 | $1.18M | Buy |
4,400
+140
| +3% | +$37.4K | 0.61% | 47 |
|
2022
Q2 | $869K | Buy |
+4,260
| New | +$869K | 0.39% | 62 |
|